연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2023년 | 2022년 | 2021년 | 2020년 | 2019년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 173편 | 163편 | 184편 | 135편 | 144편 |
| 공동 | 120편 | 115편 | 136편 | 168편 | 167편 | |
| 합계 | 293편 | 278편 | 320편 | 303편 | 311편 | |
2931. Editorial Comment: Prognostic Implications of CT-Defined Extranodal Extension of Metastatic Lymph Nodes in Patients with Non-Small Cell Lung Cancer.
Goo JM
AJR Am J Roentgenol. 2023 Oct;221(4):485
Link
2930. Conventional Versus Artificial Intelligence-Assisted Interpretation of Chest Radiographs in Patients With Acute Respiratory Symptoms in Emergency Department: A Pragmatic Randomized Clinical Trial.
Hwang EJ, Goo JM, Nam JG, Park CM, Hong KJ, Kim KH
Korean J Radiol. 2023 Mar;24(3):259-270
Link
2929. AI Improves Nodule Detection on Chest Radiographs in a Health Screening Population: A Randomized Controlled Trial
Nam JG, Hwang EJ, Kim J, Park N, Lee EH, Kim HJ, Nam M, Lee JH, Park CM, Goo JM
Radiology. 2023 Apr;307(2):e221894.
Link
2928. Triaging: Another Vital Application of the Deep Learning Technique on Chest Radiographs at the Emergency Department
Goo JM
Radiology. 2023 Feb;306(2):e223112
Link
2927. Patient-derived glioblastoma cell lines with conserved genome profiles of the original tissue
Soon-Chan Kim 1 2 3, Young-Eun Cho 1 2, Young-Kyoung Shin 1 2 3, Hyeon Jong Yu 4, Tamrin Chowdhury 4, Sojin Kim 4, Kyung Sik Yi 5, Chi-Hoon Choi 5 6, Sang-Hoon Cha 7 8, Chul-Kee Park 9, Ja-Lok Ku 10 11 12 13
Sci Data
. 2023 Jul 12;10(1):448.
Link
2926. The Impact of 131I-Metaiodobenzylguanidine as a Conditioning Regimen of Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation for High-Risk Neuroblastoma.
Park HJ, Choi JY, Kim BK, Hong KT, Kim HY, Kim IH, Cheon GJ, Cheon JE, Park SH, Kang HJ.
Children (Basel). 2023 Dec10(12):1936.
Link
2925. RE: Epigenetic profiling and response to CD19 chimeric antigen receptor T-cell therapy in B-cell malignancies.
Lee HY, Yang SB, Park MY, Baek GW, Kang HJ.
J Natl Cancer Inst. 2023 Oct115(10):1231-1233.
Link
2924. CD19 chimeric antigen receptor T cell therapy in leukemia xenograft mouse: Anti-leukemic efficacy, kinetics, and 4-week single-dose toxicity.
Kim JI, Park MY, Kwon E, Kang HJ, Kang BC.
Toxicol Appl Pharmacol. 2023 Sep475:116628.
Link
2923. Generation of antigen-specific T lymphocytes targeting Wilms tumor 1 using activated B cells.
Baek GW, Yun SO, Park MY, Kang HJ
Hum Immunol. 2023 Feb84(2):106-112.
Link
2922. Epidemiologic and Clinical Outcomes of Pediatric Renal Tumors in Korea: A Retrospective Analysis of The Korean Pediatric Hematology and Oncology Group (KPHOG) Data.
Koh KN, Han JW, Choi HS, Kang HJ, Lee JW, Yoo KH, Sung KW, Koo HH, Hong KT, Choi JY, Kang SH, Kim H, Im HJ, Hahn SM, Lyu CJ, Baek HJ, Kook H, Park KM, Yang EJ, Lim YT, Kim S, Lee JW, Chung NG, Cho B, Park M, Park HJ, Park BK, Lee JA, Park JE, Kim SK, Kim JY, Kim HS, Ma Y, Park KD, Park SK, Park ES, Shim YJ, Yoo ES, Ryu KH, Yoo JW, Lim YJ, Yoon HS, Lee MJ, Lee JM, Jeon IS, Jung HL, Chueh HW, Won S.
Cancer Res Treat. 2023 Jan55(1):279-290.
Link